BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 10, 2004
View Archived Issues
Traditional Chinese medicine shows neuroprotective effects in vivo
Read More
Chinese herb derivative attenuates neuronal damage in diabetic mice
Read More
Ista submits sNDA for Vitrase as spreading agent
Read More
New formulation of Solon launched in Japan
Read More
Lonza to manufacture Dynepo
Read More
Mycobacterial cell wall-DNA complex may present vaccine potential against bladder carcinoma
Read More
Subgroup analysis of FOCUS study in ADHD
Read More
Topline results from Opterone study
Read More
Inactine phase III study progresses
Read More
FDA clearance for Captia HSV IgG Specific ELISAs
Read More
Canadian NDS filing for Histrelin Hydrogel Implant
Read More
Hybridon licenses VEGF rights to Alnylam for ocular indications
Read More
Preclinical animal safety studies completed for CytoGenix' antiherpes compound
Read More
Cubicin phase III study cleared to continue after third safety review
Read More
First chemotherapy combination study for KRX-0401
Read More
Progression of ASCENT trial of DN-101 plus Taxotere for AIPC
Read More
Bioxalis expands pipeline
Read More
Chemotherapeutic agents target microtubules synergistically
Read More
Two series of vanilloid VR1 antagonists prepared and tested at Neurogen
Read More
New 5-HT receptor antagonists with potential as antidepressants claimed by Abbott
Read More
Novel thrombopoietin mimetics under development at GSK
Read More
Two series of NPY Y5 antagonists presented by Pfizer scientists
Read More
BMS scientists design new HER inhibitors for cancer therapy
Read More
New cathepsin inhibitors covered by AstraZeneca patent
Read More
Pfizer researchers identify novel chemokine CCR1 antagonists
Read More
EP-2104R MRI contrast agent enters clinical testing
Read More